
Fig 1. Dostinex Chemical Structure
Originally
introduced by the anti-aging community to the bodybuilding world,
this dopamine receptor agonist has the chemical name of
1-[(6-allylergolin-8ß-yl)-carbonyl]-1-[3-(dimethylamino)
propyl]-3-ethylurea and tablets of this drug include 0.5 mg of
cabergoline and the list of inactive ingredients includes leucine,
USP, lactose, and NF.
The biggest
reason
why this drug is admired by amateur and professional athletes is
because it helps them reduce or eliminate the risks associated with
excess prolactin that is common with use of harsh and aromatizable
steroids like Trenbolone and Deca Durabolin. Furthermore, this drug
is also useful for treating sexual dysfunction caused by excess
prolactin besides gaining an erection between orgasms and reducing
recovery time after intense workouts or weight training and strength
training exercises. In addition to these advantages, the use of
Dostinex is equally beneficial to combat estrogenic side effects such
as oily skin, acne, gynecomastia, and bloating and treating health
complications like galactorrhea and sexual dysfunction. It is also
routinely indicated to patients with Parkinson's disease as it has
the potential to work on information pathways and nervous system of
the body. Dostinex is also admired for its ability to make athletes
feel 'full' that helps in minimizing food cravings without dieting
discomfort.

Fig 2. Dopamine
Dostinex is
neither physically nor mentally addictive and is admired globally for
its anti-prolactin, antidepressant, cognitive, and prosexual effects.
Use of this drug for a period of six to eight weeks is also
associated with a dramatic improvement in sense of well being and
invincibility. Ideally, the recommended dose of Dostinex is 0.5 mg a
week with a glass full of water. It is very important to realize that
Dostinex (Cabergoline) is an extremely potent drug and should be used
only after receiving a prescription from a medical practitioner. The
practitioner may suggest cardiovascular evaluation and
echocardiography to evaluate valvular disease before recommending
this drug.
Use of this
drug
is not suggested to those suffering from uncontrolled hypertension or
known hypersensitivity to ergot derivatives, pregnancy-induced
hypertension, for example, preeclampsia, eclampsia, and post partum
hypertension, history of pulmonary, pericardial, or retroperitoneal
fibrotic disorders, or those having a history of cardiac valvular
disorders. Cabergoline is also not advised to those suffering from
thickening of the lining in the lungs/heart/behind the abdomen
(pulmonary/pericardial/retroperitoneal fibrosis or heart valve
disease and abnormal scarring.
People who
are
already using drugs like D2antagonists, such as phenothiazines,
butyrophenones, thioxanthenes, or metoclopramide or drugs meant to
treat migraine, mental illness, nausea, vomiting, and bacterial
infections should never use this drug concurrently unless the same is
specifically indicated by the medical practitioner. Furthermore,
children, pregnant and lactating women, or those who may become
pregnant while using it should avoid using Dostinex. The drug should
not be handled by pregnant women as it can be absorbed by the skin to
cause health complications.
Use of
Dostinex
should be stopped without any delay and medical assistance must be
sought immediately if side effects such as weakness, tiredness,
breast pain, hot flushes, dizziness, unusual sleepiness, abdominal
pain, constipation, changes in behavior, rashes, loss of hair,
irregular heart beat, breathing problems, or leg cramps or pain in
the toes or fingers are noticed.
If
Dostinex
tablets or Cabergoline injections have expired, they should not be
flushed down the toilet or poured into a drain. They should be
discarded only after consulting a pharmacist or local waste disposal
company.